We advised the underwriters on the SEC-registered equity offering

Davis Polk advised the representatives of the several underwriters in connection with the $139.7 million SEC-registered offering of 5,175,000 shares of common stock of Apria, Inc. sold by a selling stockholder, which included 675,000 shares from the full exercise of the underwriters’ over-allotment option to purchase additional shares. Apria is traded on the Nasdaq Global Select Market under the symbol “APR.”

Apria is a leading provider of integrated home healthcare equipment and related services in the United States, offering a comprehensive range of products and services for in-home care and delivery across three core service lines: (1) home respiratory therapy; (2) obstructive sleep apnea (“OSA”) treatment and (3) negative pressure wound therapy (“NPWT”). Additionally, Apria supplies a wide range of home medical equipment and other products and services to help improve the quality of life for patients with home care needs.

The Davis Polk corporate team included partner Michael Kaplan and associate Meaghan Kennedy. Counsel Kiara L. Rankin and associate Benjamin Helfgott provided tax advice. Counsel Marcie A. Goldstein provided FINRA advice. All members of the Davis Polk team are based in the New York office.

Copy link to share post